Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar Extraction
Status:
COMPLETED
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test the ability of HT-6184 to decrease inflammation and pain in patients after third molar removal.
The main question it aims to answer are:
* Does HT-6184 decrease inflammation in patients after third molar removal?
* Does HT-6184 decrease pain in patients after third molar removal?
Participants will be asked to do the following during the clinical trial:
* Take a single oral dose of HT-6184 or placebo
* Allow a oral surgeon remove their third molar teeth
* Blood draws on 5 occurrences
* Rate their pain intensity
* Attend two follow-up appointments on day 1 and day 2 after third molar removal
* Participate in one follow-up phone call 5-7 days after third molar removal